| Literature DB >> 31666069 |
Taiane Acunha Escobar1, Gabriela Dowich2, Thália Pacheco Dos Santos3, Luísa Zuravski4, Claudia Acosta Duarte5, Irina Lübeck5, Vanusa Manfredini4.
Abstract
BACKGROUND: Leishmaniosis, zoonosis that produces significant public health impacts, is caused by Leishmania infantum. Canines are the main domestic reservoir and, besides humans, other species of mammals could be infected when living in endemic areas. In this study, we detected equine Leishmania infantum infections in a canine visceral leishmaniosis transmission area and evaluated the clinical, haematological, biochemical and oxidative stress disorders. This study was conducted in Uruguaiana, Rio Grande do Sul, south of Brazil. Peripheral blood samples were collected from 124 animals (98 horses and 26 dogs) of both genders and several breeds after they underwent general and dermatologic examinations.Entities:
Keywords: Biochemical analysis; Clinical valuation; Diagnosis; Dog; Haematology; Horse; PCR
Mesh:
Substances:
Year: 2019 PMID: 31666069 PMCID: PMC6821015 DOI: 10.1186/s12917-019-2108-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Clinical signs frequency of control group and Leishmania infantum infected group by Chi-square test
| Control Group |
| ||
|---|---|---|---|
| (N/%) | (N/%) | ||
| Equine Samples Parameters | |||
| Low Body mass ( | 14 (30.43) | 3 (6.52) | 1.00 |
| Skin lesions ( | 15 (15.30) | 3 (3.06) | 1.00 |
| Lymphadenopathy ( | 2 (2.04) | 1 (1.02) | 0.90 |
| Dehydration ( | 4 (8.69) | 0 (0) | 0.97 |
| Eyes pale mucous membrane ( | 13 (23.63) | 1 (1.81) | 0.40 |
| Oral pale mucous membrane ( | 2 (4.44) | 0 (0) | 1.00 |
| Canine Samples Parameters | |||
| Low Body mass ( | 5 (20) | 5 (20) | 0.67 |
| Skin lesions ( | 3 (11.53) | 2 (7.69) | 1.00 |
| Eyes pale mucous membrane ( | 6 (25) | 3 (12.50) | 1.00 |
Comparison between parametric indices of control group and Leishmania infantum infected equines and canines
| Control Group |
| ||
|---|---|---|---|
| (X±SD) | (X±SD) | ||
| Equine Samples Parameters | |||
| CRT ( | 1.89 ± 0.43 | 2.00 ± 0.00 | 0.36 b |
| RR ( | 21.59 ± 10.86 | 18.15 ± 5.50 | 0.30 b |
| HR ( | 44.10± 13.74 | 49.23 ± 9.67 | 0.05 b* |
| BT ( | 36.97 ± 0.95 | 37.06 ± 0.76 | 0.74 a |
| Canine Samples Parameters | |||
| CRT ( | 1.75 ± 0.46 | 1.88 ± 0.64 | 0.69 b |
| RR ( | 35.20 ± 33.94 | 28.44 ± 9.26 | 0.85 b |
| HR ( | 102.40 ± 34.4 6 | 102.40 ± 20.93 | 1.00 a |
| BT ( | 38.73 ± 0.39 | 38.35 ± 0.23 | 0.00 b* |
X Mean, SD Standard Deviation; *The difference was considered significant when P value less than 0.05; a Student T test; b Wilcoxon test; CRT Capillary Refill Time, RR Respiratory Rate, HR Heart Rate, BT Body Temperature
Haematological profile in control group and Leishmania infantum infected equines and canines
| Control Group | Infected Group |
| Control Group | Infected Group |
| |
|---|---|---|---|---|---|---|
| (X±SD) | (X±SD) | (X±SD) | (X±SD) | |||
| Equine Samples | Canine Samples | |||||
| RBC (x106 cells/μL) | 7.51 ±1.26 | 6.69 ± 1.58 | 0.03 a* | 5.75 ± 0.98 | 4.90 ± 0.81 | 0.02a* |
| HCT (%) | 36.76 ± 5.52 | 32.47 ± 7.11 | 0.01 a* | 38.47 ± 7.02 | 33.38 ± 6.03 | 0.06 a |
| Hb (g/dl) | 12.48 ± 1.81 | 11.21 ± 2.32 | 0.09 b | 13.00 ± 2.86 | 11.33 ± 2.20 | 0.12 a |
| MCV (fl) | 49.17 ± 3.35 | 49.10 ± 5.01 | 0.86 a | 66.84 ± 3.71 | 67.99 ± 4.07 | 0.37 b |
| MCHC (g/dl) | 34.01 ±1.27 | 34.69 ± 1.30 | 0.06b | 33.60 ± 2.03 | 33.90 ± 1.34 | 0.24 a |
| PLT (x103 cells/μL) | 163.51 ± 119.58 | 145.50 ± 72.07 | 0.81b | 169.30 ± 101.58 | 186.45 ± 139.86 | 0.78 a |
| WBC (x103 cells/μL) | 11.88 ± 3.27 | 11.23 ±3.87 | 0.36 a | 13.87 ± 5.00 | 18.57 ± 8.22 | 0.83 a |
| Absolute Neutrophils Rods (cells/μL) | 340.48± 353.79 | 288.43 ± 229.50 | 0.72 b | 1.764 ± 2.205 | 2.231 ± 1.220 | 0.09 a |
| Relative Neutrophils Rods (%) | 2.99 ± 3.07 | 2.71 ± 2.40 | 0.99 b | 11.73 ± 10.97 | 13.18 ± 7.44 | 0.30 a |
| Absolute Neutrophils (cells/μL) | 6.118 ± 2.171 | 4.774 ± 1.598 | 0.01 a* | 7.370 ± 2.972 | 8.768 ± 5.270 | 0.44 a |
| Relative Neutrophils (%) | 51.61 ± 10.42 | 45.29 ± 14.24 | 0.11 b | 54.47 ± 18.18 | 44.27 ± 12.15 | 0.12 a |
| Absolute Eosinophils (cells/μL) | 460.75 ± 319.31 | 433.07 ± 372.51 | 0.55 b | 395.33 ± 499.66 | 511.82 ± 687.42 | 0.73 b |
| Relative Eosinophils (%) | 4.14 ± 3.08 | 4.07 ± 3.47 | 0.83 b | 2.80 ± 3.52 | 2.64 ± 2.76 | 0.81 b |
| Absolute Basophils (cells/μL) | 95.61 ± 137.59 | 148.64 ± 161.38 | 0.09 b | 96.80 ± 195.41 | 126.45 ± 170.93 | 0.49 b |
| Relative Basophils (%) | 0.80 ± 1.07 | 1.21 ± 0.89 | 0.05 b* | 0.80 ± 1.82 | 1.00 ± 1.41 | 0.47 b |
| Absolute Lymphocytes (cells/μL) | 4.444 ± 1.969 | 5.290 ± 3.543 | 0.42 a | 3.148 ± 2.093 | 5.728 ± 2.531 | 0.00 a* |
| Relative Lymphocytes (%) | 36.99 ± 10.78 | 44.36 ± 14.48 | 0.08 b | 22.20 ± 10.97 | 33.36 ±12.16 | 0.02 a* |
| Absolute Monocytes (cells/μL) | 410.63 ± 366.48 | 300.71 ± 316.82 | 0.20 b | 1.097 ± 909.43 | 1.207 ± 1.381 | 0.81 a |
| Relative Monocytes (%) | 3.31 ± 2.66 | 2.36 ± 2.13 | 0.24 b | 13.33 ± 21.77 | 5.55 ± 4.54 | 0.20 a |
| PLR | 0.04 ± 0.03 | 0.03 ± 0.02 | 0.62 b | 0.08 ± 0.11 | 0.03 ± 0.02 | 0.04b* |
| NLR | 1.68 ± 0.79 | 1.30 ± 0.78 | 0.10 a | 4.78 ± 5.22 | 2.09 ±1.13 | 0.06 b |
X Mean, SD Standard Deviation; *The difference was considered significant when P value less than 0.05; a Student T test; b Wilcoxon test; Reference values for equine specie: RBC: 6,5-12,5; HCT: 32-52; Hb: 11-19; MCV: 34-58; MCHC: 31-37; PLT: 100-600; WBC: 5.5-12.5; Neutrophils Rods: 0-100; Neutrophils: 2.700-6.700; Eosinophil: 0-925; Basophil: 0-170; Lymphocytes: 1.500-5.500; Monocytes: 0-800; Reference values for canine specie: RBC: 5,5-8,5; HCT: 37-50; Hb: 12-18; MCV: 60-67; MCHC: 32-37; PLT: 200-500; WBC: 6-17; Neutrophils Rods: 0-300; Neutrophils: 3.000-11.500; Eosinophil: 150-1.250; Basophil: 0-200; Lymphocytes: 1.000-4.800; Monocytes: 150-1.350
Biochemical profile in control group and Leishmania infantum infected equines and canines
| Control Group | Infected Group |
| Control Group | Infected Group |
| |
|---|---|---|---|---|---|---|
| (X±SD) | (X±SD) | (X±SD) | (X±SD) | |||
| Equine Samples | Canine Samples | |||||
| AST (Ul/L) | 243.60 ± 129.49 | 218.64 ± 46.41 | 0.55b | 7.83 ± 3.86 | 12.71 ± 9.19 | 0.28a |
| GGT (Ul/L) | 20.77 ± 12.49 | 15.91 ± 4.94 | 0.30 b | 5.57 ± 2.07 | 6.17 ± 3.06 | 0.68 a |
| Creatinine (mg/dL) | 1.20 ± 0.26 | 1.22 ± 0.31 | 0.96 b | 1.14 ± 0.25 | 1.15 ± 0.53 | 0.95 a |
| Urea (mg/dL) | 48.31 ± 11.46 | 57.52 ± 13.61 | 0.01a* | 24.00 ± 2.12 | 28.04 ± 19.90 | 0.96 a |
| Total Protein (g/dl) | 9.82 ± 0.99 | 9.35 ± 0.97 | 0.14 a | 6.55 ± 0.94 | 7.16 ± 0.99 | 0.22 a |
| CK (Ul/L) | 387.85 ± 212.38 | 365.91 ± 171.44 | 0.87 b |
|
| |
| ALB (g/dl) | 4.08 ± 0.49 | 4.06 ± 0.50 | 0.91a | 2.55 ± 0.50 | 2.27 ± 0.37 | 0.23 a |
| Globulin (g/dl) | 5.73 ± 1.21 | 5.29 ± 1.16 | 0.28 b | 3.99 ± 1.31 | 4.98 ± 1.29 | 0.16 a |
| Gamma Globulin | 18.81 ± 3.81 | 19.35 ± 4.89 | 0.67 a | 1.15 ± 0.41 | 1.61 ± 0.92 | 0.31a |
| A/G | 0.75 ± 0.22 | 0.63 ± 0.22 | 0.29 a | 0.75 ± 0.42 | 0.49 ± 0.18 | 0.17 a |
X Mean, SD Standard Deviation; *The difference was considered significant when P value less than 0.05; a Student T test; b Wilcoxon test. Reference values for equine specie; AST: 120-480; GGT: 10-62; Creatinine: 0.96-1.3; Urea: 21.6-51; Total Protein: 5.8-8.7; CK: 40-280; ALB: 2.6 – 3.8; Globulin: 2.5 – 4.1; Gglobulin: No reference values were found in the literature. A/G: 0.5-1.7; Reference values for canine specie: AST: 23-66; GGT: 1.2-6.4; Creatinine: 0.5-1.5; Urea: 15-65; Total Protein: 5.4-7.1; ALB: 2.6 – 3.3; Globulin: 2.5 – 4.1; Gglobulin: 0.8-1.8; A/G: 0.5-1.7
Fig. 1Markers of oxidative stress in canine and equine groups. Means ± SE in control and infected animals. 1A: plasma protein carbonyl; 1B: plasma lipid peroxidation (TBARS)